Results 81 to 90 of about 30,301 (244)
FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF [PDF]
, 2004 The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).
core
Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatment [PDF]
, 2021 Meijuan Sui +6 more
openalex +1 more source
Pulsed DC Sputter Deposition of Stable Turbostratic Boron Nitride Thin Films
Advanced Materials Interfaces, Volume 13, Issue 8, 21 April 2026.Boron nitride (BN) films are deposited by sputtering from a boron target. During deposition, a substrate bias voltage is applied between the plasma and the sample, which reduces excess boron in the film and enhances the crystallinity. This process prevents the formation of boric acid and ammonium borate hydrate.
Josef Schätz +9 more
wiley +1 more source
Advanced Science, Volume 13, Issue 24, 27 April 2026.Celastrol upregulates adipocyte‐derived exosomal miR‐5099, suppressing the macrophage c‐Met/NF‐κB axis to mitigate pro‐inflammatory M1 polarization and adipose inflammation. These miR‐5099‐enriched exosomes also act as endocrine signals targeting the liver, muscle, and adipocytes to significantly enhance systemic insulin sensitivity.
Ping Tang +9 more
wiley +1 more source
Rapid Reduction in Breast Cancer Mortality With Inorganic Arsenic in Drinking Water
EBioMedicine, 2014 Background: Arsenic trioxide is effective in treating promyelocytic leukemia, and laboratory studies demonstrate that arsenic trioxide causes apoptosis of human breast cancer cells.
Allan H. Smith +10 more
doaj +1 more source
Effective delivery of arsenic trioxide to HPV-positive cervical cancer cells using optimised liposomes: a size and charge study [PDF]
, 2018 Despite the success of arsenic trioxide (ATO) in treating haematological malignancies, its potential to treat solid tumours has not been fully exploited, owing to its dose-limiting toxicity and poor pharmacokinetics.
Akhtar, Anam +4 more
core +2 more sources
Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
Clinical, Cosmetic and Investigational Dermatology, 2011 Udensi K Udensi1,2, Barbara E Graham-Evans1, Christian Rogers1, Raphael D Isokpehi1,21RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, Jackson, MS 39217; 2Center for Bioinformatics & ...
Udensi UK +3 more
doaj
Hematology/Oncology and Stem Cell Therapy, 2011 BACKGROUND AND OBJECTIVES: The failure of existing treatments for liver cancer has recently been attribuuted to the existence of cancer stem cells, which are difficult to kill using current drugs due to their chemoresisttant properties as well as their ...
Ciprian Tomuleasa +10 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2020 Acute promyelocytic leukemia, a subtype of acute myeloid leukemia, is highly curable. In subgroup of patients with non-high-risk acute promyelocytic leukemia, intravenous arsenic trioxide plus all-trans-retinoic acid is considered the preferred regimen ...
Natthaporn Sasijareonrat MD +3 more
doaj +1 more source